The role of hematological biomarkers, coagulation profile and CRP (c-reactive protein) in COVID-19 patients in private health care sector

SARS-CoV-2 causing corona virus disease 2019 (COVID-19) is the most common infection in recent days worldwide. Rapidly evolving from epidemic outbreak Wuhan, China on 29 December 2019, third known that causes fatal respiratory diseases humans. The roles of biomarkers a blood sample diagnosis COVID-19 patients who have visited hospital with history fever has been evaluated. A retrospective study was carried out private sector at Panipat where having were admitted during 1st May 2020 to 15th August 2020. total 100 included suspected cases corona. All parameters, systemic inflammatory index (SII), neutrophil lymphocyte ratio (NLR) and platelet (PLR) Coagulation factor (prothrombin time (PT), activated partial thromboplastin (aPTT), international normalized (INR) C-Reactive protein (CRP) are compared between negative positive according RT-PCR. Result: Out patients, 65% RTPCR covid positive. In patient test results, it found leukocyte count, neutrophils, platelet, NLR SII values higher. However, haemoglobin, lymphocytes PLR be elevated results. presented leukopenia, neutropenia, thrombocytopenia lymphocytosis. reduced. CRP increased. PT APTT within normal limits. Lymphocyte count showed strong significance this study. definitive made by RT-PCR analysis, but time-consuming less accessible test. Low high value indicative can used its diagnosis.